Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
Expanding the dimension of blood purification Working to save lives together.
DGTHG 2025

Lunch Symposium: Hemoadsorption as safety net in cardiac surgery | 15. February, 13:45-14:45, Hamburg

Details
35. Intensivmedizin Bremen

Symposium: Hämoadsorption in der Intensivmedizin – Best Practice | 13. February, 11:15-12:45, Bremen

Details
New Blog Post

Prof. Daniel Wendt on the results of the second interim STAR Registry analysis

Read more
CytoSorbents & Hemoadsorption

When it comes to critical health challenges, count on us.

We understand that healthcare professionals need to be able to rely on technology that protects patients.

 

CytoSorbents’ powerful adsorption technology is expanding the dimensions of blood purification, with one of the fastest ways to restore balance and control damage – beyond what dialysis can do.

Our Innovation

The incomparable power of bead technology

Our solutions are based on our proprietary biocompatible, highly porous polymer bead technology, which works to effectively, safely, and selectively remove excessive levels of potentially harmful substances.

Our Team of Experts

Expertise you can count on the moment you need it.

Our Support

CytoSorbents in over 75 countries worldwide.

CytoSorbents

Voices around the world

world map
Critical Care
Dr. Maroua Eid
France, Angers

This case describes the successful use of CytoSorb with CRRT and extracorporeal life support in a combined way to overcome a critical phase of septic shock.

Critical Care
Dr. Christopher Rugg
Austria, Innsbruck

Catecholamines decreased within 24 h after initiation of CytoSorb Therapy; in-hospital mortality was significantly lower in the CytoSorb group (35.7% vs 61.9%).

Cardiovascular
Dr. L. Christian Napp
Germany, Hannover

In the most critically ill patients on ECMO support, we observed a drop in catecholamine demand and an improvement in clinical state on ECMO.